Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| N/A | 0 | 0 | 0 | 0 | 0 | — | 0 |
| NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES | 221,152 | 0 | -221,152 | 4,527 | 0 | — | -4,527 |
| ARCUS BIOSCIENCES INC(RCUS) | 731,818 | 0 | -731,818 | 5,745 | 0 | — | -5,745 |
| CENTESSA PHARMACEUTICALS PLC | 418,127 | 0 | -418,127 | 6,013 | 0 | — | -6,013 |
| AGIOS PHARMACEUTICALS INC(AGIO) | 235,350 | 0 | -235,350 | 6,896 | 0 | — | -6,896 |
| CYTOKINETICS INC(CYTK) | 175,000 | 0 | -175,000 | 7,033 | 0 | — | -7,033 |
| HALOZYME THERAPEUTICS INC(HALO) | 120,000 | 0 | -120,000 | 7,657 | 0 | — | -7,657 |
| SUMMIT THERAPEUTICS INC(SMMT) | 400,000 | 0 | -400,000 | 7,716 | 0 | — | -7,716 |
| MADRIGAL PHARMACEUTICALS INC(MDGL) | 24,000 | 0 | -24,000 | 7,950 | 0 | — | -7,950 |
| VERONA PHARMA PLC | 160,000 | 0 | -160,000 | 10,158 | 0 | — | -10,158 |
| TARSUS PHARMACEUTICALS INC(TARS) | 205,000 | 0 | -205,000 | 10,531 | 0 | — | -10,531 |
| ROYALTY PHARMA PLC(RPRX) | 356,894 | 0 | -356,894 | 11,110 | 0 | — | -11,110 |
| TEVA PHARMACEUTICAL INDS LTD(TEVA) | 801,806 | 0 | -801,806 | 12,324 | 0 | — | -12,324 |
| ROIVANT SCIENCES LTD(ROIV) | 1,300,000 | 0 | -1,300,000 | 13,117 | 0 | — | -13,117 |
| PERRIGO CO PLC(PRGO) | 479,517 | 0 | -479,517 | 13,446 | 0 | — | -13,446 |
| BRIDGEBIO PHARMA INC(BBIO) | 390,644 | 0 | -390,644 | 13,505 | 0 | — | -13,505 |
| ULTRAGENYX PHARMACEUTICAL IN(RARE) | 379,303 | 0 | -379,303 | 13,735 | 0 | — | -13,735 |
| INSMED INC(INSM) | 186,384 | 0 | -186,384 | 14,219 | 0 | — | -14,219 |
| ELI LILLY & CO(LLY) | 18,000 | 0 | -18,000 | 14,866 | 0 | — | -14,866 |
| BIOGEN INC(BIIB) | 113,500 | 0 | -113,500 | 15,531 | 0 | — | -15,531 |
| AMGEN INC(AMGN) | 50,000 | 0 | -50,000 | 15,578 | 0 | — | -15,577 |
| BRISTOL-MYERS SQUIBB CO(BMY) | 295,000 | 0 | -295,000 | 17,992 | 0 | — | -17,992 |